Emergent Medical Partners Raises $37M Toward Second Fund
September 17, 2013
Life sciences investment firm Emergent Medical Partners is targeting $50 million for its second fund and has already raised $37 million, according to an SEC filing. Emergent, which closed its first fund at $70 million in 2007, focuses on early stage medical device and healthcare companies. The firm has seen a handful of exits, including Incline Therapeutics, which was acquired by The Medicines Company for $185 million earlier this year, and Evalve, which was acquired by Abbott Laboratories for $320 million in 2009.